PL362788A1 - Kompozycja farmaceutyczna dronedaronu do podawania pozajelitowego - Google Patents

Kompozycja farmaceutyczna dronedaronu do podawania pozajelitowego

Info

Publication number: PL362788A1
Authority: PL; Poland
Prior art keywords: pharmaceutical; parenteral administration; dronedarone; composition; dronedarone composition
Prior art date: 2000-12-11

Application number

PL01362788A

Other languages

English (en)

Other versions

PL199846B1 (pl

Inventor

Frederique Bourriague-Seve

Thierry Breul

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-11

Filing date

2001-12-10

Publication date

2004-11-02

2001-12-10 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2004-11-02 Publication of PL362788A1 publication Critical patent/PL362788A1/pl

2008-11-28 Publication of PL199846B1 publication Critical patent/PL199846B1/pl

Links

ZQTNQVWKHCQYLQ-UHFFFAOYSA-N dronedarone Chemical compound C1=CC(OCCCN(CCCC)CCCC)=CC=C1C(=O)C1=C(CCCC)OC2=CC=C(NS(C)(=O)=O)C=C12 ZQTNQVWKHCQYLQ-UHFFFAOYSA-N 0.000 title 1
229960002084 dronedarone Drugs 0.000 title 1
238000007911 parenteral administration Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

PL362788A 2000-12-11 2001-12-10 Kompozycja farmaceutyczna dronedaronu do podawania pozajelitowego PL199846B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0016071A FR2817750B1 (fr)	2000-12-11	2000-12-11	Composition pharmaceutique de dronedarone pour administration parenterale
PCT/FR2001/003903 WO2002047660A1 (fr)	2000-12-11	2001-12-10	Composition pharmaceutique de dronedarone pour administration parenterale

Publications (2)

Publication Number	Publication Date
PL362788A1 true PL362788A1 (pl)	2004-11-02
PL199846B1 PL199846B1 (pl)	2008-11-28

Family

ID=8857483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL362788A PL199846B1 (pl)	2000-12-11	2001-12-10	Kompozycja farmaceutyczna dronedaronu do podawania pozajelitowego

Country Status (30)

Country	Link
US (1)	US6939865B2 (pl)
EP (1)	EP1343473B1 (pl)
JP (1)	JP4399161B2 (pl)
KR (1)	KR100849758B1 (pl)
CN (1)	CN1235566C (pl)
AR (1)	AR031649A1 (pl)
AT (1)	ATE348599T1 (pl)
AU (2)	AU2002217229B2 (pl)
BG (1)	BG66187B1 (pl)
BR (1)	BR0116060B1 (pl)
CA (1)	CA2427375C (pl)
CZ (1)	CZ297788B6 (pl)
DE (1)	DE60125411T2 (pl)
EA (1)	EA005314B1 (pl)
FR (1)	FR2817750B1 (pl)
HU (1)	HU229372B1 (pl)
IL (2)	IL155428A0 (pl)
IS (1)	IS2349B (pl)
MA (1)	MA26969A1 (pl)
ME (2)	MEP20408A (pl)
MX (1)	MXPA03005221A (pl)
NO (1)	NO332294B1 (pl)
NZ (1)	NZ525661A (pl)
OA (1)	OA12416A (pl)
PL (1)	PL199846B1 (pl)
RS (1)	RS50348B (pl)
SK (1)	SK287115B6 (pl)
TW (1)	TWI246926B (pl)
WO (1)	WO2002047660A1 (pl)
ZA (1)	ZA200303406B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR059574A1 (es) *	2006-02-14	2008-04-16	Wyeth Corp	Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta
GB0719180D0 (en)	2007-10-02	2007-11-14	Cambrex Karlskoga Ab	New process
FR2930149B1 (fr) *	2008-04-17	2011-02-18	Sanofi Aventis	Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2684564A1 (en) *	2008-04-17	2014-01-15	Sanofi	Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation
EP2116239A1 (en) *	2008-04-29	2009-11-11	Sanofi-Aventis	Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
FR2959132A1 (fr) *	2010-04-22	2011-10-28	Sanofi Aventis	Procedes pour l'evaluation et la reduction des risques
TWI508726B (zh)	2009-12-21	2015-11-21	Gilead Sciences Inc	治療心房纖維性顫動之方法
US20120005128A1 (en) *	2010-06-29	2012-01-05	Sanofi	Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en)	2010-06-30	2013-12-10	Sanofi	Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh)	2010-07-30	2012-02-08	江苏恒瑞医药股份有限公司	决奈达隆固体分散体及其制备方法
KR20120094557A (ko) *	2011-02-01	2012-08-27	동아제약주식회사	피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
CN102908307A (zh) *	2011-08-03	2013-02-06	天津市嵩锐医药科技有限公司	供注射用盐酸决奈达隆药物组合物及其制备方法
BR112015000497A2 (pt) *	2012-07-12	2017-06-27	Sanofi Sa	composição anti-tumoral compreendendo o composto 1-(6-{[6-(4-fluorofenil)[1,2,4]triazolo[4,3-b]piridazin-3-il]sulfanil}-1,3-benzotiazol-2-il)-3-(2-morfolin-4-iletil)ureia
CN114377148B (zh) *	2020-10-20	2023-09-29	上海博志研新药物研究有限公司	盐酸决奈达隆药物组合物、其制备方法及应用
CN115702878B (zh) *	2021-08-16	2024-05-10	上海云晟研新生物科技有限公司	盐酸决奈达隆注射组合物、其制备方法及应用
AU2023387777A1 (en) *	2022-12-07	2024-08-29	Remegen Co., Ltd.	Taci-fc fusion protein liquid pharmaceutical preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4727064A (en) *	1984-04-25	1988-02-23	The United States Of America As Represented By The Department Of Health And Human Services	Pharmaceutical preparations containing cyclodextrin derivatives
FR2746013B1 (fr) *	1996-03-18	1998-05-29	Sanofi Sa	Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP2004327321A (ja) *	2003-04-25	2004-11-18	Jst Mfg Co Ltd	コネクタ

2000
- 2000-12-11 FR FR0016071A patent/FR2817750B1/fr not_active Expired - Fee Related
2001
- 2001-12-10 KR KR1020037007744A patent/KR100849758B1/ko not_active Expired - Fee Related
- 2001-12-10 ZA ZA200303406A patent/ZA200303406B/en unknown
- 2001-12-10 ME MEP-204/08A patent/MEP20408A/xx unknown
- 2001-12-10 AU AU2002217229A patent/AU2002217229B2/en not_active Ceased
- 2001-12-10 AR ARP010105716A patent/AR031649A1/es not_active Application Discontinuation
- 2001-12-10 AT AT01270322T patent/ATE348599T1/de not_active IP Right Cessation
- 2001-12-10 US US10/450,320 patent/US6939865B2/en not_active Expired - Lifetime
- 2001-12-10 WO PCT/FR2001/003903 patent/WO2002047660A1/fr not_active Ceased
- 2001-12-10 RS YUP-465/03A patent/RS50348B/sr unknown
- 2001-12-10 CA CA2427375A patent/CA2427375C/fr not_active Expired - Fee Related
- 2001-12-10 ME MEP-2008-204A patent/ME00083B/me unknown
- 2001-12-10 CN CNB018203884A patent/CN1235566C/zh not_active Expired - Fee Related
- 2001-12-10 IL IL15542801A patent/IL155428A0/xx active IP Right Grant
- 2001-12-10 HU HU0500842A patent/HU229372B1/hu not_active IP Right Cessation
- 2001-12-10 OA OA1200300152A patent/OA12416A/fr unknown
- 2001-12-10 BR BRPI0116060-5B1A patent/BR0116060B1/pt not_active IP Right Cessation
- 2001-12-10 NZ NZ525661A patent/NZ525661A/en not_active IP Right Cessation
- 2001-12-10 DE DE60125411T patent/DE60125411T2/de not_active Expired - Lifetime
- 2001-12-10 SK SK726-2003A patent/SK287115B6/sk not_active IP Right Cessation
- 2001-12-10 MX MXPA03005221A patent/MXPA03005221A/es active IP Right Grant
- 2001-12-10 EP EP01270322A patent/EP1343473B1/fr not_active Expired - Lifetime
- 2001-12-10 TW TW090130522A patent/TWI246926B/zh not_active IP Right Cessation
- 2001-12-10 PL PL362788A patent/PL199846B1/pl unknown
- 2001-12-10 AU AU1722902A patent/AU1722902A/xx active Pending
- 2001-12-10 JP JP2002549234A patent/JP4399161B2/ja not_active Expired - Fee Related
- 2001-12-10 CZ CZ20031612A patent/CZ297788B6/cs not_active IP Right Cessation
- 2001-12-10 EA EA200300406A patent/EA005314B1/ru not_active IP Right Cessation
2003
- 2003-04-14 IL IL155428A patent/IL155428A/en not_active IP Right Cessation
- 2003-04-18 BG BG107748A patent/BG66187B1/bg unknown
- 2003-04-29 NO NO20031958A patent/NO332294B1/no not_active IP Right Cessation
- 2003-04-30 IS IS6801A patent/IS2349B/is unknown
- 2003-06-03 MA MA27190A patent/MA26969A1/fr unknown

Also Published As

Publication number	Publication date
CZ297788B6 (cs)	2007-03-28
PL199846B1 (pl)	2008-11-28
ME00083B (me)	2010-10-10
NO332294B1 (no)	2012-08-20
AU1722902A (en)	2002-06-24
NO20031958L (no)	2003-06-11
US20040044070A1 (en)	2004-03-04
DE60125411T2 (de)	2007-10-11
IL155428A (en)	2007-10-31
BR0116060B1 (pt)	2013-12-31
EP1343473A1 (fr)	2003-09-17
SK7262003A3 (en)	2004-02-03
ATE348599T1 (de)	2007-01-15
MEP20408A (en)	2010-06-10
WO2002047660A1 (fr)	2002-06-20
KR100849758B1 (ko)	2008-07-31
EP1343473B1 (fr)	2006-12-20
US6939865B2 (en)	2005-09-06
AR031649A1 (es)	2003-09-24
NZ525661A (en)	2004-11-26
AU2002217229B2 (en)	2006-05-18
CN1235566C (zh)	2006-01-11
HUP0500842A2 (hu)	2005-12-28
IS2349B (is)	2008-04-15
CA2427375A1 (fr)	2002-06-20
TWI246926B (en)	2006-01-11
CN1479610A (zh)	2004-03-03
EA005314B1 (ru)	2004-12-30
EA200300406A1 (ru)	2003-10-30
JP2004528277A (ja)	2004-09-16
HU229372B1 (en)	2013-11-28
BR0116060A (pt)	2004-03-02
FR2817750B1 (fr)	2003-02-21
BG66187B1 (bg)	2011-12-30
CZ20031612A3 (cs)	2003-09-17
KR20030060985A (ko)	2003-07-16
ZA200303406B (en)	2004-05-03
RS50348B (sr)	2009-11-10
IS6801A (is)	2003-04-30
BG107748A (bg)	2004-03-31
MA26969A1 (fr)	2004-12-20
JP4399161B2 (ja)	2010-01-13
SK287115B6 (sk)	2009-12-07
OA12416A (fr)	2006-04-18
CA2427375C (fr)	2011-02-01
YU46503A (sh)	2006-08-17
MXPA03005221A (es)	2004-03-26
HK1055906A1 (en)	2004-01-30
IL155428A0 (en)	2003-11-23
FR2817750A1 (fr)	2002-06-14
DE60125411D1 (de)	2007-02-01
NO20031958D0 (no)	2003-04-29

Publication	Publication Date	Title
EG24357A (en)	2009-03-04	New Pharmaceutical composition
IL152659A0 (en)	2003-06-24	Pharmaceutical composition
SI1524266T1 (sl)	2007-08-31	Farmacevtski sestavek
GB0001621D0 (en)	2000-03-15	Pharmaceutical compositions
HUP0204555A3 (en)	2004-06-28	Pharmaceutical composition
AU6219601A (en)	2001-10-30	Pharmaceutical compositions
GB0009584D0 (en)	2000-06-07	Pharmaceutical compositions
IL155428A0 (en)	2003-11-23	Pharmaceutical dronedarone composition for parenteral administration
AU2002217229A1 (en)	2002-08-29	Pharmaceutical dronedarone composition for parenteral administration
AU8576801A (en)	2002-01-02	Pharmaceutical compositions
IL154238A0 (en)	2003-09-17	Pharmaceutical composition
GB0008485D0 (en)	2000-05-24	Pharmaceutical compositions
GB0009613D0 (en)	2000-06-07	Pharmaceutical compositions
GB0005382D0 (en)	2000-04-26	Pharmaceutical composition
GB0002691D0 (en)	2000-03-29	Pharmaceutical composition
GB0101094D0 (en)	2001-02-28	Pharmaceutical composition
GB0011725D0 (en)	2000-07-05	Pharmaceutical composition for anthelmintics
GB0011724D0 (en)	2000-07-05	Pharmaceutical composition for anthelmintics
SI1313467T1 (sl)	2006-02-28	Nov farmacevtski sestavek za dajanje N-0923
GB0016684D0 (en)	2000-08-23	Pharmaceutical composition
GB0027375D0 (en)	2000-12-27	Pharmaceutical composition
GB0026716D0 (en)	2000-12-20	Pharmaceutical composition
GB0019599D0 (en)	2000-09-27	Pharmaceutical composition
GB0006301D0 (en)	2000-05-03	Pharmaceutical composition
GB0011734D0 (en)	2000-07-05	Pharmaceutical composition for anthelmintics (1)